NeuroMetrix, Inc. reported the publication of a large study demonstrating that DPNCheck effectively determines the severity of diabetic peripheral neuropathy (DPN). DPNCheck is a widely used point-of-care test that provides fast, accurate and cost-effective screening, diagnosis and monitoring of peripheral neuropathies. It is often used to stage the severity of DPN, which is the most common specific cause of peripheral nerve disease and a ubiquitous long-term complication of diabetes that may lead to foot ulcers and amputation. The study by Dr. Hideki Kamiya and colleagues evaluated 375 individuals with Type II diabetes at Aichi Medical University Hospital (Nagakute, Japan). Each subject was evaluated with the DPNCheck device and a gold standard nerve conduction study (NCS) using traditional electromyography equipment. DPN severity was graded using an NCS based classification system. DPNCheck effectively identified subjects with moderate to severe DPN (area under ROC of 0.87) and early signs of nerve dysfunction (area under ROC 0.83).